These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37970604)

  • 1. A machine learning-based algorithm to eliminate breast and axillary surgery in patients with breast cancer and pathological complete response after neoadjuvant chemotherapy.
    de Nonneville A; Boudin L; Houvenaeghel G; Gonçalves A; Bertucci F
    Ann Transl Med; 2023 Oct; 11(11):397. PubMed ID: 37970604
    [No Abstract]   [Full Text] [Related]  

  • 2. De-escalating Surgery Among Patients with HER2 + and Triple Negative Breast Cancer.
    Tasoulis MK; Heil J; Kuerer HM
    Curr Breast Cancer Rep; 2022; 14(4):135-141. PubMed ID: 35915668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the Axilla and the Breast After Neoadjuvant Chemotherapy in Patients with Breast Cancer: A Systematic Review.
    Citgez B; Yigit B; Yetkin SG
    Sisli Etfal Hastan Tip Bul; 2021; 55(2):156-161. PubMed ID: 34349589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-escalation of Axillary Surgery in the Neoadjuvant Chemotherapy (NACT) Setting for Breast Cancer: Is it Oncologically Safe?
    Wazir U; Mokbel K
    Anticancer Res; 2020 Oct; 40(10):5351-5354. PubMed ID: 32988853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?
    Morgan C; Stringfellow TD; Rolph R; Kovacs T; Kothari A; Pinder SE; Hamed H; Sever AR
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):522-526. PubMed ID: 31740186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer.
    Skarping I; Förnvik D; Zackrisson S; Borgquist S; Rydén L
    Breast Cancer Res Treat; 2021 Aug; 189(1):131-144. PubMed ID: 34120224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy following neoadjuvant chemotherapy: an evidence-based review and recommendations for current practice.
    Cavalcante FP; Millen EC; Novita GG; Zerwes FP; Mattar A; Machado RHS; Frasson AL
    Chin Clin Oncol; 2023 Feb; 12(1):6. PubMed ID: 36922355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between tumor molecular subtype, clinical stage and axillary pathological response in breast cancer patients undergoing complete pathological remission after neoadjuvant chemotherapy: potential implications for de-escalation of axillary surgery.
    Hong J; Tong Y; He J; Chen X; Shen K
    Ther Adv Med Oncol; 2021; 13():1758835921996673. PubMed ID: 33737963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of ultrasound in the clinical re-staging of the axilla after neoadjuvant chemotherapy (NACT).
    Peppe A; Wilson R; Pope R; Downey K; Rusby J
    Breast; 2017 Oct; 35():104-108. PubMed ID: 28704697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Definitive results.
    Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
    Surg Oncol; 2021 Sep; 38():101636. PubMed ID: 34303211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer.
    Huang Y; Chen W; Zhang X; He S; Shao N; Shi H; Lin Z; Wu X; Li T; Lin H; Lin Y
    Front Bioeng Biotechnol; 2021; 9():662749. PubMed ID: 34295877
    [No Abstract]   [Full Text] [Related]  

  • 12. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study.
    Qian B; Yang J; Zhou J; Hu L; Zhang S; Ren M; Qu X
    Front Endocrinol (Lausanne); 2022; 13():955250. PubMed ID: 36060977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy.
    Weiss A; Bashour SI; Hess K; Thompson AM; Ibrahim NK
    Breast Cancer Res; 2018 Apr; 20(1):27. PubMed ID: 29661243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual Axillary Burden After Neoadjuvant Chemotherapy (NACT) in Early Breast Cancer in Patients with a priori Clinically Occult Nodal Metastases - a transSENTINA Analysis.
    Kolberg HC; Kühn T; Krajewska M; Bauerfeind I; Fehm TN; Fleige B; Helms G; Lebeau A; Stäbler A; Schmatloch S; Hausschild M; Schwentner L; Schrenk P; Loibl S; Untch M; Kolberg-Liedtke C
    Geburtshilfe Frauenheilkd; 2020 Dec; 80(12):1229-1236. PubMed ID: 33293731
    [No Abstract]   [Full Text] [Related]  

  • 15. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implications of a pathological complete response of the primary tumour after neoadjuvant chemotherapy for breast cancer on axillary surgery.
    Youssef MMG; Metwally AA; Manie TM
    J Egypt Natl Canc Inst; 2021 Feb; 33(1):5. PubMed ID: 33555499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Pathological Complete Response Rate of Less than 10 Total Axillary Lymph Nodes After Axillary Lymph Node Dissection Following Neoadjuvant Chemotherapy in Breast Cancer.
    Lee J; Park NJ; Kang B; Jung JH; Kim WW; Chae YS; Lee SJ; Kim HJ; Park JY; Park HY
    Front Surg; 2022; 9():678169. PubMed ID: 35433822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: Combined sentinel node-radioguided surgery of the pathological node.
    Fuertes Manuel J; Kohan S; Jordà Solé M; Mateu Hidalgo I; Miralles Curto M; Aguiló Sagristà O; Aguilar Alomá E; Peña González K; Lafuerza Torres A; Melé Olivé M; Repkova J; Montero Jaime MJ; Gumà Padró J
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(5):284-291. PubMed ID: 35597764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypes.
    Barrou J; Bannier M; Cohen M; Lambaudie E; Gonçalves A; Bertrand P; Buttarelli M; Opinel P; Sterkers N; Tallet A; Zinzindohoué C; Houvenaeghel G
    Breast; 2017 Apr; 32():37-43. PubMed ID: 28033508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mammograms using artificial intelligence to predict response to neoadjuvant chemotherapy in breast cancer patients: proof of concept.
    Skarping I; Larsson M; Förnvik D
    Eur Radiol; 2022 May; 32(5):3131-3141. PubMed ID: 34652522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.